12 May 2022
The development and delivery of new diagnostic solutions to remote communities in Australia, New Zealand and internationally is the goal of a new strategic partnership between Australian medical research organisation, Burnet Institute, and New Zealand biotech company, Orbis Diagnostics.
The partnership will bring together Burnet’s research excellence and Orbis’ expertise in the production of lab-quality, point-of-care diagnostics to accelerate the development of a suite of finger-prick blood tests for infectious disease and liver health.
Jennifer Barnes, Director of Burnet Diagnostics Initiative said developing simple, accurate diagnostic tests that can be easily operated in remote and rural areas is essential to improving the health of communities globally.
“A key challenge to delivering health care in rural communities is access. Removing the waiting time for diagnostic test results will be a major step towards helping address this challenge. Our focus has been on the development of lateral flow tests, but the partnership with Orbis Diagnostics will allow us to develop our biomarkers into multiple test formats and reach more communities in need,” Ms Barnes said.
Read the full press release below.